Showing results (61-70 of 182) with videos related to
Sort By:
Pageof 19
Journal of Enzyme Inhibition and Medicinal Chemistry|January 11, 2022
Multi-stage structure-based virtual screening approach towards identification of potential SARS-CoV-2 NSP13 helicase inhibitorsMahmoud A El Hassab, Wagdy M Eldehna, Sara T Al-Rashood, et al.Frontiers in Oncology|June 19, 2023
A multi-class deep learning model for early lung cancer and chronic kidney disease detection using computed tomography imagesAnanya Bhattacharjee, Sameh Rabea, Abhishek Bhattacharjee, et al.RSC Advances|May 2, 2022
Design, synthesis, docking study and anticancer evaluation of new trimethoxyphenyl pyridine derivatives as tubulin inhibitors and apoptosis inducersMohamed Hagras, Asmaa A Mandour, Esraa A Mohamed, et al.RSC Advances|April 3, 2023
Synchronized electrochemical detection of hydroquinone and catechol in real water samples using a Co@SnO2-polyaniline compositeQasar Saleem, Sammia Shahid, Mohsin Javed, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|April 26, 2022
Identification of 3-(piperazinylmethyl)benzofuran derivatives as novel type II CDK2 inhibitors: design, synthesis, biological evaluation, and in silico insightsWagdy M Eldehna, Raed M Maklad, Hadia Almahli, et al.RSC Advances|April 24, 2025
Targeting VEGFR-2 in breast cancer: synthesis and in silico and in vitro characterization of quinoxaline-based inhibitorsIbrahim H Eissa, Alaa Elwan, Mustafa A Al-Qadhi, et al.Future Medicinal Chemistry|May 19, 2026
New chromene derivatives as promising VEGFR-2 inhibitors: combined experimental, DFT, and molecular dynamics approachesEslam B Elkaeed, Hazem Elkady, Walid E Elgammal, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|July 13, 2022
Design, synthesis, and anti-cancer evaluation of new pyrido[2,3-d]pyrimidin-4(3H)-one derivatives as potential EGFRWT and EGFRT790M inhibitors and apoptosis inducersHeba S A Elzahabi, Eman S Nossier, Rania A Alasfoury, et al.Evolutionary Bioinformatics Online|December 4, 2023
Computer-Assisted Drug Discovery of a Novel Theobromine Derivative as an EGFR Protein-Targeted Apoptosis InducerIbrahim H Eissa, Reda G Yousef, Eslam B Elkaeed, et al.Current Pharmaceutical Design|November 30, 2023
Design, Molecular Modeling, MD Simulations, Essential Dynamics, ADMET, DFT, Synthesis, Anti-proliferative, and Apoptotic Evaluations of a New Anti-VEGFR-2 Nicotinamide AnalogueIbrahim H Eissa, Eslam B Elkaeed, Hazem Elkady, et al.Pageof 19